Annexon Analyst Ratings
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
H.C. Wainwright Maintains Annexon(ANNX.US) With Buy Rating, Maintains Target Price $30
A Quick Look at Today's Ratings for Annexon(ANNX.US), With a Forecast Between $14 to $30
Annexon Price Target Maintained With a $30.00/Share by HC Wainwright & Co.
Needham Reiterates Buy on Annexon, Maintains $16 Price Target
Annexon Analyst Ratings
Buy Rating Justified: Undervalued Annexon Biosciences Poised for Growth With Positive Clinical Trials and Strong Cash Position
Annexon Biosciences: Accelerated Timelines and Financial Stability Bolster Buy Rating
Analysts Offer Insights on Healthcare Companies: Green Thumb Industries (OtherGTBIF) and Annexon Biosciences (ANNX)
TD Cowen Maintains Annexon(ANNX.US) With Buy Rating
Annexon Biosciences (ANNX) Receives a Buy From TD Cowen
Annexon Analyst Ratings
Annexon Analyst Ratings
Wells Fargo Maintains Overweight on Annexon, Lowers Price Target to $10
Analysts Offer Insights on Healthcare Companies: Alcon (ALC), Annexon Biosciences (ANNX) and Ascendis Pharma (ASND)
Annexon Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Annexon, Maintains $30 Price Target
Buy Rating on Annexon Biosciences Backed by Efficacious ANX007 Data and Meticulous Phase 3 Trial Design
Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (ZBH), Annexon Biosciences (ANNX) and Cytokinetics (CYTK)